CompletedPhase 2NCT00334074

Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS

Studying C syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Baylor Research Institute
Principal Investigator
Edward Agura, MD
Baylor University Medical Center - Director Blood and Marrow Transplantation Services
Intervention
Clofarabine and Cytarabine(drug)
Enrollment
30 enrolled
Eligibility
18-85 years · All sexes
Timeline
20052008

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00334074 on ClinicalTrials.gov

Other trials for C syndrome

Additional recruiting or active studies for the same condition.

See all trials for C syndrome

← Back to all trials